慢性阻塞性肺病的新药发现策略:最新的发展
Luigino Calzetta1, Elena Pistocchini2, Shima Gholamalishahi2
1Respiratory Disease and Lung Function Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Expert opinion on drug discovery
|April 14, 2025
概括
慢性阻塞性肺病 (COPD) 药物发现的新战略正在出现. 先进的体外模型和药物重定向显示出更有效的COPD治疗方法的前景.
科学领域:
- 肺部医学和药理学 肺部医学和药理学
- 药物发现和开发 药物发现和开发
背景情况:
- 呼吸系统疾病药物发现是漫长的 (10.4年) 和昂贵的 (2.8亿美元),涉及目标识别,分子发现,临床前测试,临床试验和监管批准.
- 慢性阻塞性肺病 (COPD) 呈现出大量未满足的医疗需求,有效治疗方法有限.
- 目前用于COPD的药物发现策略需要创新来改善治疗结果.
研究的目的:
- 审查COPD的新药发现策略.
- 专注于用于准确药物测试的先进体外模型.
- 探索向的分子疗法,基于结构的药物设计和计算药物重新定位.
主要方法:
- 基于搜索字符串的文献综述:发现和策略和COPD.
- 检查复制人类肺部状况的先进体外模型.
- 对向分子疗法,基于结构的药物设计和计算药物重新定位方法的分析.
主要成果:
- 创新的体外模型对于在COPD中进行准确的药物测试至关重要.
- 有针对性的分子疗法和基于结构的药物设计为COPD治疗提供了新的途径.
- 通过计算分析促进的药物重新定位,有望加速COPD治疗的发展.
结论:
- 先进的临床前模型和药物重定向策略可以改变COPD治疗模式.
- 个性化医疗方法对于将治疗量身定制为不同COPD患者的个人资料至关重要.
- 这些创新旨在提高药物发现效率,从而带来更有效,更精确的COPD疗法.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
133
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
133
01:20COPD: Pathogenesis and Clinical Features
185
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
185
01:17Drugs Used in Lower Respiratory Disorders: Overview
260
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
260